|
Accelr8 Technology Corporation - Comparative Business Analysis Snapshot
Business Description
Accelr8 Technology Corporation. The Company's principal activity is to develop and commercialize innovative, integrated system for rapid identification of bacteria and their antibiotic resistance in critically ill patients. The major products include BACcelr8r(tm), OptiChem(r), OptArray(TM). BACcelr8r(tm) intended to be used in clinical diagnostics for life-threatening bacterial infections. OptiChem(r) is into surface coatings and assay processing methods. OptArray(TM) produces micro arraying slides and also develops OptiPlate(TM) arrayable microtiter plates. The Company is granted license to Schott Jenaer Glas GmbH (SCHOTT), for manufacturing and marketing OptiChem microarraying products. The major trade marks include BACcelr8r, OptArray(TM),OptiChem(R), OptiPlate(TM),QuanDx(TM),YoDx(TM) and Quantum Microbiology(TM). The Company's office and laboratory is situated in Colorado.
Competitor Analysis
This analysis compares Accelr8 Technology Corporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
